In the dynamic landscape of diabetic macular edema management, the PALADIN study continues to offer helpful insights into the outcomes of IOP-lowering surgery after treatment with Iluvien.
The comprehensive 3-year phase 4 study with 202 eyes of 159 patients reaffirms the successful patient outcomes associated with IOP-lowering surgery and highlights key factors influencing these outcomes.
The study aims to simplify the nuanced landscape of IOP-lowering surgery and its impact on DME management in this specific patient population. Out of the 202 eyes enrolled, eight eyes required surgery, three